Feasibility of a New Technology for Isolating Circulating Tumour Cells
Conditions: HER2-positive Metastatic Breast Cancer; Ovarian Cancer; Hormone-resistant Prostate Cancer; Circulating Tumor Cell Intervention: Procedure: Blood sample collection Sponsor: Centre Oscar Lambret Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials